GSA CAPITAL PARTNERS LLP

Position in GH — Guardant Health, Inc.

CIK 1362033 LONDON, X0

Position in GH

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,772,004

+$1,347,102 QoQ

Shares Held

11,811

+156.8% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.12%

of 13F equity value

Holder Rank

#270

of 593 holders

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

GSA CAPITAL PARTNERS LLP holds $16,598,580 across 18 Diagnostics & Research names. GH ranks #3 (10.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NTRA	Natera, Inc.	11,336	$3,077,157
2	TMO	Thermo Fisher Scientific Inc.	4,702	$2,357,394
3	GH	Guardant Health, Inc. This page	11,811	$1,772,004
4	BDSX	Biodesix Inc	46,989	$1,059,601
5	DGX	Quest Diagnostics Inc	4,971	$1,053,603
6	IDXX	Idexx Laboratories Inc /De	1,981	$1,042,877
7	XGN	Exagen Inc.	214,721	$998,452
8	MTD	Mettler Toledo International Inc/	619	$790,778

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,772,004	11,811	+156.8%	Shares	Sole	2026-08-06
2026-03-31	$424,902	4,600	+1.6%	Shares	Sole	2026-05-08
2025-12-31	$462,489	4,528	-79.4%	Shares	Sole	2026-02-06
2025-09-30	$1,373,435	21,982	+155.5%	Shares	Sole	2025-11-07
2025-06-30	$447,752	8,604	-65.8%	Shares	Sole	2025-07-22
2024-12-31	$769,249	25,180	+52.7%	Shares	Sole	2025-02-07
2024-09-30	$378,257	16,489	-13.2%	Shares	Sole	2024-11-05
2024-06-30	$548,691	18,999	-39.3%	Shares	Sole	2024-08-15
2024-03-31	$645,533	31,291	+269.7%	Shares	Sole	2024-05-03
2023-12-31	$228,924	8,463	-41.7%	Shares	Sole	2024-02-16
2023-03-31	$340,067	14,508	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.